FDA Alert
FDA Alert
03/19/2024

Jessica Ganga

Jessica Ganga
The FDA approved two gene therapies, the first of their kind, to treat patients aged 12 years and older with sickle cell disease.
03/19/2024
Conference Coverage
Conference Coverage
12/18/2023

Anthony Calabro, MA

Anthony Calabro, MA
In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
12/18/2023
Conference Coverage
Conference Coverage
12/12/2023

Anthony Calabro, MA

Anthony Calabro, MA
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
12/12/2023
Research Summary
Research Summary
08/02/2023
Researchers sought to establish the global disease burden of sickle cell disease and its mortality rate.
08/02/2023
sickle cell disease
sickle cell disease
08/09/2018
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
08/09/2018
sickle cell disease
sickle cell disease
08/03/2018
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
08/03/2018
sickle cell disease
sickle cell disease
07/07/2017
The US Food and Drug Administration recently approved a new oral treatment for adult and pediatric patients with sickle cell disease.
07/07/2017